Loading…

Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment

Purpose To explore factors related to pathogenesis of rhegmatogenous retinal detachment (RRD) and development of proliferative vitreoretinopathy (PVR), vitreous levels of angiopoietin-1 and −2 (Ang-1 and −2), previously undefined in RRD, transforming growth factor-(TGF) β1, vascular endothelial grow...

Full description

Saved in:
Bibliographic Details
Published in:Graefe's archive for clinical and experimental ophthalmology 2014-06, Vol.252 (6), p.881-888
Main Authors: Loukovaara, Sirpa, Lehti, Kaisa, Robciuc, Alexandra, Pessi, Timo, Holopainen, Juha M., Koli, Katri, Immonen, Ilkka, Keski-Oja, Jorma
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3
cites cdi_FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3
container_end_page 888
container_issue 6
container_start_page 881
container_title Graefe's archive for clinical and experimental ophthalmology
container_volume 252
creator Loukovaara, Sirpa
Lehti, Kaisa
Robciuc, Alexandra
Pessi, Timo
Holopainen, Juha M.
Koli, Katri
Immonen, Ilkka
Keski-Oja, Jorma
description Purpose To explore factors related to pathogenesis of rhegmatogenous retinal detachment (RRD) and development of proliferative vitreoretinopathy (PVR), vitreous levels of angiopoietin-1 and −2 (Ang-1 and −2), previously undefined in RRD, transforming growth factor-(TGF) β1, vascular endothelial growth factor (VEGF), erythropoietin (EPO) and proteolytic mediators of extracellular matrix remodelling (MMP-2 and −9) were compared in eyes with RRD and eyes with idiopathic macular hole or pucker. Methods Vitreous samples were collected from 117 eyes with RRD (study group) and 40 eyes with macular hole or pucker (control group). Growth factors were measured by ELISA and matrix metalloproteinases (MMPs) by gelatin zymography. Results The mean vitreous concentrations of Ang-2, MMP-2, and MMP-9 were higher (all p  
doi_str_mv 10.1007/s00417-013-2508-z
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1530320347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1530320347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3</originalsourceid><addsrcrecordid>eNp1kM1KAzEYRYMoWqsP4EYG3LiJfkkmprMU8adQcKPQlSHNfNOmzE9N0op9elNaRQRXIeTcm8sh5IzBFQNQ1wEgZ4oCE5RLGND1HumxXEiqgI_3SQ8UZ3Qg-PiIHIcwh4QLyQ7JEc85G6Rsj7wNW-vRBCwz10ZvVi6ma52Zduq6RecwupbyrMYV1iEzIXTWmZjoDxdnmZ_htDGxm2LbLUPmN3QKlxiNnTXYxhNyUJk64Onu7JPXh_uXuyc6en4c3t2OqBWKRyqNMUJONvNQYgWVKsrqhsuCgbKW56VSBTOW46RAhlXBJRcWCmlvygpFaUSfXG57F757X2KIunHBYl2bFtMyzaQAwUHkKqEXf9B5t_Rp9o5ikBcsUWxLWd-F4LHSC-8a4z81A72Rr7fydZKvN_L1OmXOd83LSYPlT-LbdgL4FgjpqZ2i__X1v61fw-qRVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1530310491</pqid></control><display><type>article</type><title>Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment</title><source>Springer Link</source><creator>Loukovaara, Sirpa ; Lehti, Kaisa ; Robciuc, Alexandra ; Pessi, Timo ; Holopainen, Juha M. ; Koli, Katri ; Immonen, Ilkka ; Keski-Oja, Jorma</creator><creatorcontrib>Loukovaara, Sirpa ; Lehti, Kaisa ; Robciuc, Alexandra ; Pessi, Timo ; Holopainen, Juha M. ; Koli, Katri ; Immonen, Ilkka ; Keski-Oja, Jorma</creatorcontrib><description>Purpose To explore factors related to pathogenesis of rhegmatogenous retinal detachment (RRD) and development of proliferative vitreoretinopathy (PVR), vitreous levels of angiopoietin-1 and −2 (Ang-1 and −2), previously undefined in RRD, transforming growth factor-(TGF) β1, vascular endothelial growth factor (VEGF), erythropoietin (EPO) and proteolytic mediators of extracellular matrix remodelling (MMP-2 and −9) were compared in eyes with RRD and eyes with idiopathic macular hole or pucker. Methods Vitreous samples were collected from 117 eyes with RRD (study group) and 40 eyes with macular hole or pucker (control group). Growth factors were measured by ELISA and matrix metalloproteinases (MMPs) by gelatin zymography. Results The mean vitreous concentrations of Ang-2, MMP-2, and MMP-9 were higher (all p  &lt; 0.01), whereas concentration of VEGF was lower ( p  = 0.01) in eyes with RRD relative to controls. Logistic regression analysis identified Ang-2 concentration as a novel marker of RRD ( p  = 0.0001, OR 48.7). Ang-1, EPO, and total TGF-β1 levels were not significantly different between the groups. However, TGF-β1 and MMP-2 were increased in eyes with total RRD compared to those with local RRD ( p  ≤ 0.05). In eyes with PVR, no differences were observed in any studied marker as compared with non-PVR eyes. Conclusions Current results reveal Ang-2 as a key factor upregulated in RRD. It may co-operate with fibrosis-associated factors and contribute to vascular complications such as breakdown of blood–eye barrier and PVR development.</description><identifier>ISSN: 0721-832X</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/s00417-013-2508-z</identifier><identifier>PMID: 24218041</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Angiopoietin-1 - metabolism ; Angiopoietin-2 - metabolism ; Biomarkers - metabolism ; Enzyme-Linked Immunosorbent Assay ; Erythropoietin - metabolism ; Female ; Humans ; Male ; Matrix Metalloproteinases - metabolism ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Ophthalmology ; Prospective Studies ; Retinal Detachment - diagnosis ; Retinal Detachment - metabolism ; Retinal Disorders ; Transforming Growth Factor beta1 - metabolism ; Vascular Endothelial Growth Factor A - metabolism ; Vitreous Body - metabolism</subject><ispartof>Graefe's archive for clinical and experimental ophthalmology, 2014-06, Vol.252 (6), p.881-888</ispartof><rights>Springer-Verlag Berlin Heidelberg 2013</rights><rights>Springer-Verlag Berlin Heidelberg 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3</citedby><cites>FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24218041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Loukovaara, Sirpa</creatorcontrib><creatorcontrib>Lehti, Kaisa</creatorcontrib><creatorcontrib>Robciuc, Alexandra</creatorcontrib><creatorcontrib>Pessi, Timo</creatorcontrib><creatorcontrib>Holopainen, Juha M.</creatorcontrib><creatorcontrib>Koli, Katri</creatorcontrib><creatorcontrib>Immonen, Ilkka</creatorcontrib><creatorcontrib>Keski-Oja, Jorma</creatorcontrib><title>Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment</title><title>Graefe's archive for clinical and experimental ophthalmology</title><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><description>Purpose To explore factors related to pathogenesis of rhegmatogenous retinal detachment (RRD) and development of proliferative vitreoretinopathy (PVR), vitreous levels of angiopoietin-1 and −2 (Ang-1 and −2), previously undefined in RRD, transforming growth factor-(TGF) β1, vascular endothelial growth factor (VEGF), erythropoietin (EPO) and proteolytic mediators of extracellular matrix remodelling (MMP-2 and −9) were compared in eyes with RRD and eyes with idiopathic macular hole or pucker. Methods Vitreous samples were collected from 117 eyes with RRD (study group) and 40 eyes with macular hole or pucker (control group). Growth factors were measured by ELISA and matrix metalloproteinases (MMPs) by gelatin zymography. Results The mean vitreous concentrations of Ang-2, MMP-2, and MMP-9 were higher (all p  &lt; 0.01), whereas concentration of VEGF was lower ( p  = 0.01) in eyes with RRD relative to controls. Logistic regression analysis identified Ang-2 concentration as a novel marker of RRD ( p  = 0.0001, OR 48.7). Ang-1, EPO, and total TGF-β1 levels were not significantly different between the groups. However, TGF-β1 and MMP-2 were increased in eyes with total RRD compared to those with local RRD ( p  ≤ 0.05). In eyes with PVR, no differences were observed in any studied marker as compared with non-PVR eyes. Conclusions Current results reveal Ang-2 as a key factor upregulated in RRD. It may co-operate with fibrosis-associated factors and contribute to vascular complications such as breakdown of blood–eye barrier and PVR development.</description><subject>Aged</subject><subject>Angiopoietin-1 - metabolism</subject><subject>Angiopoietin-2 - metabolism</subject><subject>Biomarkers - metabolism</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Erythropoietin - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Matrix Metalloproteinases - metabolism</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Prospective Studies</subject><subject>Retinal Detachment - diagnosis</subject><subject>Retinal Detachment - metabolism</subject><subject>Retinal Disorders</subject><subject>Transforming Growth Factor beta1 - metabolism</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Vitreous Body - metabolism</subject><issn>0721-832X</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp1kM1KAzEYRYMoWqsP4EYG3LiJfkkmprMU8adQcKPQlSHNfNOmzE9N0op9elNaRQRXIeTcm8sh5IzBFQNQ1wEgZ4oCE5RLGND1HumxXEiqgI_3SQ8UZ3Qg-PiIHIcwh4QLyQ7JEc85G6Rsj7wNW-vRBCwz10ZvVi6ma52Zduq6RecwupbyrMYV1iEzIXTWmZjoDxdnmZ_htDGxm2LbLUPmN3QKlxiNnTXYxhNyUJk64Onu7JPXh_uXuyc6en4c3t2OqBWKRyqNMUJONvNQYgWVKsrqhsuCgbKW56VSBTOW46RAhlXBJRcWCmlvygpFaUSfXG57F757X2KIunHBYl2bFtMyzaQAwUHkKqEXf9B5t_Rp9o5ikBcsUWxLWd-F4LHSC-8a4z81A72Rr7fydZKvN_L1OmXOd83LSYPlT-LbdgL4FgjpqZ2i__X1v61fw-qRVQ</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Loukovaara, Sirpa</creator><creator>Lehti, Kaisa</creator><creator>Robciuc, Alexandra</creator><creator>Pessi, Timo</creator><creator>Holopainen, Juha M.</creator><creator>Koli, Katri</creator><creator>Immonen, Ilkka</creator><creator>Keski-Oja, Jorma</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment</title><author>Loukovaara, Sirpa ; Lehti, Kaisa ; Robciuc, Alexandra ; Pessi, Timo ; Holopainen, Juha M. ; Koli, Katri ; Immonen, Ilkka ; Keski-Oja, Jorma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Angiopoietin-1 - metabolism</topic><topic>Angiopoietin-2 - metabolism</topic><topic>Biomarkers - metabolism</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Erythropoietin - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Matrix Metalloproteinases - metabolism</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Prospective Studies</topic><topic>Retinal Detachment - diagnosis</topic><topic>Retinal Detachment - metabolism</topic><topic>Retinal Disorders</topic><topic>Transforming Growth Factor beta1 - metabolism</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Vitreous Body - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Loukovaara, Sirpa</creatorcontrib><creatorcontrib>Lehti, Kaisa</creatorcontrib><creatorcontrib>Robciuc, Alexandra</creatorcontrib><creatorcontrib>Pessi, Timo</creatorcontrib><creatorcontrib>Holopainen, Juha M.</creatorcontrib><creatorcontrib>Koli, Katri</creatorcontrib><creatorcontrib>Immonen, Ilkka</creatorcontrib><creatorcontrib>Keski-Oja, Jorma</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Loukovaara, Sirpa</au><au>Lehti, Kaisa</au><au>Robciuc, Alexandra</au><au>Pessi, Timo</au><au>Holopainen, Juha M.</au><au>Koli, Katri</au><au>Immonen, Ilkka</au><au>Keski-Oja, Jorma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment</atitle><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle><stitle>Graefes Arch Clin Exp Ophthalmol</stitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>252</volume><issue>6</issue><spage>881</spage><epage>888</epage><pages>881-888</pages><issn>0721-832X</issn><eissn>1435-702X</eissn><abstract>Purpose To explore factors related to pathogenesis of rhegmatogenous retinal detachment (RRD) and development of proliferative vitreoretinopathy (PVR), vitreous levels of angiopoietin-1 and −2 (Ang-1 and −2), previously undefined in RRD, transforming growth factor-(TGF) β1, vascular endothelial growth factor (VEGF), erythropoietin (EPO) and proteolytic mediators of extracellular matrix remodelling (MMP-2 and −9) were compared in eyes with RRD and eyes with idiopathic macular hole or pucker. Methods Vitreous samples were collected from 117 eyes with RRD (study group) and 40 eyes with macular hole or pucker (control group). Growth factors were measured by ELISA and matrix metalloproteinases (MMPs) by gelatin zymography. Results The mean vitreous concentrations of Ang-2, MMP-2, and MMP-9 were higher (all p  &lt; 0.01), whereas concentration of VEGF was lower ( p  = 0.01) in eyes with RRD relative to controls. Logistic regression analysis identified Ang-2 concentration as a novel marker of RRD ( p  = 0.0001, OR 48.7). Ang-1, EPO, and total TGF-β1 levels were not significantly different between the groups. However, TGF-β1 and MMP-2 were increased in eyes with total RRD compared to those with local RRD ( p  ≤ 0.05). In eyes with PVR, no differences were observed in any studied marker as compared with non-PVR eyes. Conclusions Current results reveal Ang-2 as a key factor upregulated in RRD. It may co-operate with fibrosis-associated factors and contribute to vascular complications such as breakdown of blood–eye barrier and PVR development.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>24218041</pmid><doi>10.1007/s00417-013-2508-z</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0721-832X
ispartof Graefe's archive for clinical and experimental ophthalmology, 2014-06, Vol.252 (6), p.881-888
issn 0721-832X
1435-702X
language eng
recordid cdi_proquest_miscellaneous_1530320347
source Springer Link
subjects Aged
Angiopoietin-1 - metabolism
Angiopoietin-2 - metabolism
Biomarkers - metabolism
Enzyme-Linked Immunosorbent Assay
Erythropoietin - metabolism
Female
Humans
Male
Matrix Metalloproteinases - metabolism
Medicine
Medicine & Public Health
Middle Aged
Ophthalmology
Prospective Studies
Retinal Detachment - diagnosis
Retinal Detachment - metabolism
Retinal Disorders
Transforming Growth Factor beta1 - metabolism
Vascular Endothelial Growth Factor A - metabolism
Vitreous Body - metabolism
title Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A02%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20intravitreal%20angiopoietin-2%20levels%20associated%20with%20rhegmatogenous%20retinal%20detachment&rft.jtitle=Graefe's%20archive%20for%20clinical%20and%20experimental%20ophthalmology&rft.au=Loukovaara,%20Sirpa&rft.date=2014-06-01&rft.volume=252&rft.issue=6&rft.spage=881&rft.epage=888&rft.pages=881-888&rft.issn=0721-832X&rft.eissn=1435-702X&rft_id=info:doi/10.1007/s00417-013-2508-z&rft_dat=%3Cproquest_cross%3E1530320347%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-5aaa35b0435e5ef0f79df6259107cc24d7791ac2eb9e1ef92523c095c6dfe3da3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1530310491&rft_id=info:pmid/24218041&rfr_iscdi=true